This conference will offer a broad perspective of state-of-the-art approaches leveraging molecular engineering, cellular engineering and materials engineering for the manipulation of the human genome and epigenome, the immune system and diseased tissue, in the contexts of therapy, diagnostics, disease modelling and drug discovery, and across a broad range of disease types. The focus will be on engaging discussions about how to best harness human biology to devise strategies for probing, diagnosing and combating human disease.
This event has passed.